公司資料
BioStem Technologies 股價、新聞與催化劑
- 股票代碼:
- BSEM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.00 USD (-6.54%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
Following the latest company update, “BioStem Technologies to Present at the Sidoti MicroCap Conference”, BSEM closed down 6.54% at $3.00 on Aug 17, 2026. The move occurred in the trading session associated with this conference / presentation update.
公司概覽
Perinatal Tissue Regenerative Medicine Company
BioStem Technologies develops, manufactures, and commercializes allograft products derived from perinatal tissue. Its products are used across multiple specialties, particularly surgical care and wound management.
Processing Technology and Product Portfolio
The company uses proprietary BioRetain, CryoTek, and SteriTek processing methods intended to preserve the natural properties of donated tissue. Its brands include Neox, Clarix, VENDAJE, and American Amnion.
Hospital Commercialization Transition
Following the acquisition of BioTissue surgical and wound-care assets, BioStem is building a broader hospital-focused commercial organization, expanding its direct sales team and group purchasing organization coverage. The release did not identify a specific asset-level clinical or regulatory catalyst.
未來催化劑
- BioStem Technologies’ catalysts are wound-care product adoption and any commercial update that shows the regenerative-medicine platform is scaling. The market will care about recurring demand.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。